Search - tctmd.com

Displaying 1 - 20 of 217

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Daily News

Alterations in Alcohol Use, Even at Low Levels, Impact BP

Todd Neale

October 24, 2025

News Conference News HFSA 2025

Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74

Yael L. Maxwell

September 30, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

Caitlin E. Cox

July 23, 2025

News Opinion Fellow Talk

The Hidden Demands of Cardiology Training

Tushar Mishra, MD

July 09, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News European Congress on Obesity 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

L.A. McKeown

April 14, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

Advertisement

TCTMD’s Top 10 Most Popular Stories for January 2026

Heart Disease Remains Number One Killer of Americans

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Women’s Heart Health in the Spotlight

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Frail Patients Stand to Gain Most From Cardiac Rehab

Alterations in Alcohol Use, Even at Low Levels, Impact BP

Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

July 2025 Dispatch for the CV Team

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

The Hidden Demands of Cardiology Training

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content